These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37343690)

  • 1. Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications.
    Yu M; Hu S; Tang B; Yang H; Sun D
    Biotechnol Adv; 2023 Oct; 67():108202. PubMed ID: 37343690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics.
    Lynch JP; Goers L; Lesser CF
    Trends Pharmacol Sci; 2022 Sep; 43(9):772-786. PubMed ID: 35232591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.
    Ou B; Yang Y; Tham WL; Chen L; Guo J; Zhu G
    Appl Microbiol Biotechnol; 2016 Oct; 100(20):8693-9. PubMed ID: 27640192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology.
    Ba F; Zhang Y; Ji X; Liu WQ; Ling S; Li J
    Biotechnol J; 2024 Jan; 19(1):e2300327. PubMed ID: 37800393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a new T7 promoter compatible Escherichia coli Nissle 1917 strain for recombinant production of heme-dependent proteins.
    Fiege K; Frankenberg-Dinkel N
    Microb Cell Fact; 2020 Oct; 19(1):190. PubMed ID: 33023596
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhang Y; Ji W; He L; Chen Y; Ding X; Sun Y; Hu S; Yang H; Huang W; Zhang Y; Liu F; Xia L
    Theranostics; 2018; 8(6):1690-1705. PubMed ID: 29556350
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of probiotic E. coli Nissle 1917 for β-alanine production by using protein and metabolic engineering.
    Hu S; Fei M; Fu B; Yu M; Yuan P; Tang B; Yang H; Sun D
    Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2277-2288. PubMed ID: 36929190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient markerless integration of genes in the chromosome of probiotic E. coli Nissle 1917 by bacterial conjugation.
    Seco EM; Fernández LÁ
    Microb Biotechnol; 2022 May; 15(5):1374-1391. PubMed ID: 34755474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering the probiotic bacterium Escherichia coli Nissle 1917 as an efficient cell factory for heparosan biosynthesis.
    Hu S; Zhao L; Hu L; Xi X; Zhang Y; Wang Y; Chen J; Chen J; Kang Z
    Enzyme Microb Technol; 2022 Aug; 158():110038. PubMed ID: 35453037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective and challenges of live bacterial therapeutics from a superhero
    Effendi SSW; Ng IS
    Crit Rev Microbiol; 2023 Sep; 49(5):611-627. PubMed ID: 35947523
    [No Abstract]   [Full Text] [Related]  

  • 11. Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy.
    Li R; Helbig L; Fu J; Bian X; Herrmann J; Baumann M; Stewart AF; Müller R; Li A; Zips D; Zhang Y
    Res Microbiol; 2019 Mar; 170(2):74-79. PubMed ID: 30447257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins.
    Seo EJ; Weibel S; Wehkamp J; Oelschlaeger TA
    Int J Med Microbiol; 2012 Nov; 302(6):276-87. PubMed ID: 22748509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redesign of an Escherichia coli Nissle treatment for phenylketonuria using insulated genomic landing pads and genetic circuits to reduce burden.
    Triassi AJ; Fields BD; Monahan CE; Means JM; Park Y; Doosthosseini H; Padmakumar JP; Isabella VM; Voigt CA
    Cell Syst; 2023 Jun; 14(6):512-524.e12. PubMed ID: 37348465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic
    Kim D; Kim Y; Yoon SH
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672760
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-native Pathway Engineering with CRISPRi for Carbon Dioxide Assimilation and Valued 5-Aminolevulinic Acid Synthesis in
    Effendi SSW; Ng IS
    ACS Synth Biol; 2024 Jul; 13(7):2038-2044. PubMed ID: 38954490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of cadmium- and mercury-induced liver and kidney damage in rats by genetically engineered probiotic Escherichia coli Nissle 1917 producing pyrroloquinoline quinone with oral supplementation of citric acid.
    Raghuvanshi R; Chaudhari A; Kumar GN
    Nutrition; 2016; 32(11-12):1285-94. PubMed ID: 27209211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification.
    Datta P; Fu L; Brodfuerer P; Dordick JS; Linhardt RJ
    Appl Microbiol Biotechnol; 2021 Feb; 105(3):1051-1062. PubMed ID: 33481068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic circuits for feedback control of gamma-aminobutyric acid biosynthesis in probiotic
    Lebovich M; Andrews LB
    bioRxiv; 2023 Jun; ():. PubMed ID: 37333167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917.
    van 't Hof M; Mohite OS; Monk JM; Weber T; Palsson BO; Sommer MOA
    BMC Bioinformatics; 2022 Dec; 23(1):566. PubMed ID: 36585633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Circuits for Feedback Control of Gamma-Aminobutyric Acid Biosynthesis in Probiotic
    Lebovich M; Lora MA; Gracia-David J; Andrews LB
    Metabolites; 2024 Jan; 14(1):. PubMed ID: 38248847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.